Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-11-14Clinical Trial Update: A Registry Study of the AeriSeal® System or Lung Volume Reduction in Patients With Advanced Emphysema
The registry study evaluating the AeriSeal System for lung volume reduction in advanced emphysema/COPD has been terminated.
-
CLINICAL_TRIALS withdrawal · 2013-11-14Clinical Trial Update: Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emphysema [Phase 3]
Phase 3 trial of the AeriSeal System for advanced non-upper lobe predominant heterogeneous emphysema has been withdrawn from further study.
-
CLINICAL_TRIALS trial_result · 2013-11-14Clinical Trial Update: Effect of Ketoconazole on Breathlessness [Phase 4]
Phase 4 clinical trial assessing the effect of ketoconazole on breathlessness in chronic obstructive pulmonary disease has completed with re…
-
CLINICAL_TRIALS trial_result · 2013-11-13Clinical Trial Update: The Study Will Evaluate the Effect of AZD8683 in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
A Phase 2 trial evaluating AZD8683 in chronic obstructive pulmonary disease has completed, and results were posted on 2013-11-13.
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects [Phase 3]
Phase 3 safety study evaluating arformoterol tartrate inhalation solution in adults with chronic obstructive pulmonary disease; the trial is…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Pilot Study Comparing Tiotropium (Spiriva) to Salmeterol (Serevent) Plus Fluticasone (Flixotide) in Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
A Phase 4 pilot trial compares tiotropium alone to a combination of salmeterol and fluticasone for chronic obstructive pulmonary disease; th…
-
CLINICAL_TRIALS withdrawal · 2013-11-11Clinical Trial Update: A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD [Phase 3]
A Phase 3 trial comparing QVA149 (indacaterol/glycopyrronium) to Fluticasone/Salmeterol (Advair) for chronic obstructive pulmonary disease h…
-
CLINICAL_TRIALS withdrawal · 2013-11-11Clinical Trial Update: A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD [Phase 3]
A 12-week Phase 3 trial comparing QVA149 (indacaterol/glycopyrronium) to Fluticasone/Salmeterol (Advair) for COPD was withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Human Immunodeficiency Virus (HIV)and Chronic Obstructive Pulmonary Disease (COPD) [NA]
This document notes the completion of a clinical trial examining Chronic Obstructive Pulmonary Disease in individuals with HIV infection.
-
CLINICAL_TRIALS trial_result · 2013-11-07Clinical Trial Update: Long Term Safety and Tolerability of QVA149 Versus Tiotropium in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 clinical trial update comparing long-term safety and tolerability of QVA149 (indacaterol/glycopyrronium) versus tiotropium in Japane…
-
CLINICAL_TRIALS trial_result · 2013-11-07Clinical Trial Update: Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis [Phase 2]
Phase 2 clinical trial comparing two regimens to reduce Pseudomonas aeruginosa infection in children with cystic fibrosis. The study is comp…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Spiriva® Assessment of FEV1 (SAFE) [Phase 3]
The Phase 3 SAFE trial evaluating Spiriva (tiotropium) for FEV1 assessment in chronic obstructive pulmonary disease has completed. The entry…
-
CLINICAL_TRIALS trial_result · 2013-11-05Clinical Trial Update: Efficacy and Safety of Tiotropium Inhalation Capsules and Atrovent MDI in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial update evaluating the efficacy and safety of tiotropium inhalation capsules and Atrovent MDI (ipratropium) in patients with ch…
-
CLINICAL_TRIALS trial_result · 2013-11-05Clinical Trial Update: A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases. [Phase 3]
Phase 3 trial comparing tiotropium inhalation once daily versus salmeterol inhalation twice daily in COPD, evaluating arterial blood gases.
-
CLINICAL_TRIALS research · 2013-11-05Clinical Trial Update: Continuous Positive Airway Pressure (CPAP) Ventilation Using a Novel Full-Face Mask Versus Conventional Helmet [NA]
ClinicalTrials.gov update indicates the study comparing a novel full-face CPAP mask with a conventional helmet for respiratory support has b…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Effects of a 9-months Treatment of SPIRIVA on Health Related Quality of Life in Patients With COPD [Phase 3]
A Phase 3 clinical trial evaluating the effects of nine months of SPIRIVA on health-related quality of life in patients with chronic obstruc…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A Phase 3 clinical trial update on tiotropium 18 mcg once daily via HandiHaler for chronic obstructive pulmonary disease. The study status i…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Comparison of Tiotropium and Ipratropium in a Double-Blind, Double-dummy, Efficacy and Safety Study in Adults With COPD [Phase 3]
A Phase 3 trial comparing tiotropium and ipratropium in adults with chronic obstructive pulmonary disease completed.
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Efficacy and Safety (Including 24-hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPD [Phase 3]
A Phase 3 trial update reports on the efficacy and safety of tiotropium inhalation capsules in patients with chronic obstructive pulmonary d…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Tiotropium Bromide Inhalation Powder 18mcg Once Daily in Subjects With COPD Who Have or Are At Risk for Co-morbid Cardiovascular Disease [Phase 3]
This entry reports the completion and posted results of a Phase 3 trial comparing Fluticasone Furoate/Vilanterol inhalation powder (FF/VI) t…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Acute Bronchodilator Response of a Single Dose of Atrovent or Berotec on Top of Pharmacodynamic Steady State of Spiriva [Phase 3]
This Phase 3 trial by Boehringer Ingelheim evaluated the acute bronchodilator response of ipratropium (Atrovent) or fenoterol (Berotec) adde…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary Disease [Phase 4]
This Phase 4 clinical trial evaluates the efficacy of tiotropium in patients with chronic obstructive pulmonary disease, including a focus o…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: 12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD [Phase 3]
A Phase 3 trial comparing 5 mcg and 10 mcg doses of tiotropium delivered by Respimat against placebo and ipratropium MDI in chronic obstruct…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: A Six-week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
A six-week Phase 4 trial compares the efficacy and safety of tiotropium plus formoterol against salmeterol plus fluticasone in chronic obstr…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Mechanisms of Dyspnea Relief During Exercise in COPD Patients Following Treatment With Tiotropium (Spiriva) [Phase 3]
This document provides an update on a Phase 3 COPD trial evaluating tiotropium's ability to relieve dyspnea during exercise. The study was c…